Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Merck combination treatment for lung cancer fails late-stage study
Reuters
Thu, 03/21/24 - 11:13 am
Merck
Keytruda
Lynparza
AstraZeneca
non small cell lung cancer
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data
BioSpace
Fri, 03/15/24 - 11:28 am
Merck
Keytruda
cervical cancer
clinical trials
Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office
Fierce Pharma
Thu, 03/14/24 - 11:29 am
Merck
Johns Hopkins
Keytruda
patents
Merck to start trials investigating single dosing regiments of HPV vaccine
Clinical Trials Arena
Wed, 03/13/24 - 10:55 am
Merck
HPV
vaccines
Gardasil 9
clinical trials
Merck bets up to $1B on Pearl's 'smart' biomaterial jewels as biotech begins to raise fresh funds
Fierce Biotech
Tue, 03/12/24 - 11:12 am
Merck
Pearl Bio
cancer
biologics
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
oncology
cancer
antibody-drug conjugate
Merck
AbbVie
Pfizer
AstraZeneca
Merck to open new distribution centre in Brazil for Life Science sector
Pharmaceutical Business Review
Wed, 02/28/24 - 10:30 am
Merck
Brazil
distribution
Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
BioSpace
Tue, 02/27/24 - 10:18 am
Merck
patents
Hikma
Bridion
muscle relaxants
generics
Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster
First Word Pharma
Thu, 02/22/24 - 11:43 am
Samsung Bioepis
Merck
biosimilars
Keytruda
clinical trials
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive
Fri, 02/9/24 - 11:26 am
Senate
drug pricing
Pharma CEOs
Bristol Myers Squibb
Chris Boerner
JNJ
Joaquin Duato
Merck
Rob Davis
PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US
Fierce Pharma
Thu, 02/8/24 - 10:08 pm
Bernie Sanders
drug pricing
Pharma CEOs
Senate
Merck
Bristol Myers Squibb
JNJ
Rob Davis
Chris Boerner
Joaquin Duato
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
Motley Fool
Thu, 02/8/24 - 10:01 pm
Merck
Eli Lilly
Novo Nordisk
weight loss
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
Fierce Pharma
Tue, 02/6/24 - 11:33 pm
Bernie Sanders
drug pricing
Merck
JNJ
Bristol Myers Squibb
Pharma CEOs
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
Merck still in the market for deals in the $1B to $15B range, CEO says
Fierce Pharma
Thu, 02/1/24 - 10:56 pm
Merck
M&A
Pharma CEOs
Rob Davis
Prometheus Biosciences
Merck seeks more deals to prepare for Keytruda's revenue decline
Yahoo/Reuters
Thu, 02/1/24 - 11:24 am
Merck
earnings
Keytruda
Merck inks research deal with Culmination Bio to leverage ‘powerful’ patient data platform
Biopharma Reporter
Tue, 01/30/24 - 10:32 am
Merck
Culmination Bio
Intermountain Health
R&D
J&J, Merck CEOs to testify at Senate panel after Sanders’ subpoena threats
Medical Marketing and Media
Mon, 01/29/24 - 10:32 pm
JNJ
Merck
Pharma CEOs
Joaquin Duato
Robert Davis
Senate
drug pricing
Bernie Sanders
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer
Fierce Pharma
Fri, 01/26/24 - 12:03 pm
Merck
Keytruda
bladder cancer
Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says
Stat
Thu, 01/25/24 - 09:14 pm
drug pricing
Bernie Sanders
Pharma CEOs
Merck
Robert Davis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »